Main Risks of Xarelto Before Surgery
Xarelto (rivaroxaban) is a direct oral anticoagulant that inhibits factor Xa, increasing bleeding risk during surgery. Primary concerns include excessive intraoperative or postoperative bleeding, hematoma formation, and transfusion needs. Unlike warfarin, it lacks a direct reversal agent in all settings, though andexanet alfa (Andexxa) can reverse it for urgent cases.[1][2]
How Long Before Surgery Should You Stop Xarelto?
Guidelines from the American College of Chest Physicians recommend stopping Xarelto 24-48 hours preoperatively for low-bleeding-risk procedures (e.g., dental work, cataract surgery) and 48-72 hours for high-bleeding-risk ones (e.g., neurosurgery, cardiac surgery), based on CrCl and procedure type. For CrCl >50 mL/min, aim for 24 hours pre-low-risk; extend for renal impairment.[3][4]
| Procedure Bleeding Risk | CrCl >50 mL/min | CrCl 30-50 mL/min | CrCl <30 mL/min |
|-------------------------|------------------|-------------------|-----------------|
| Low (e.g., minor dental) | Stop 24h before | Stop 36h before | Stop ≥48h before |
| High (e.g., spinal, major ortho) | Stop ≥48h before | Stop ≥48h before | Stop ≥72h before |
Bridging Therapy: Do You Need It?
Bridging with heparin is often unnecessary for Xarelto due to its short half-life (5-13 hours in healthy adults, longer with age/renal issues). American Society of Hematology guidelines advise against routine bridging for most nonvalvular AF patients to avoid rebound thrombosis or excess bleeding.[5]
Reversal Options If Bleeding Occurs
- Andexanet alfa: Specific reversal for urgent surgery; reduces anti-Xa activity by 90%+ within minutes.[2]
- Prothrombin complex concentrate (PCC): 25-50 units/kg if andexanet unavailable; success in 80-90% of cases.[6]
- Timing matters: Full reversal may take 2-24 hours post-last dose.
Special Patient Risks
- Renal impairment: Half-life extends to 20+ hours if CrCl <30 mL/min, heightening bleed risk.[1]
- Elderly or low weight: Higher plasma levels increase hemorrhage odds by 1.5-2x.[4]
- Concurrent meds: Avoid with strong CYP3A4/P-gp inhibitors (e.g., ketoconazole); risk of supratherapeutic levels.[7]
- Spinal/epidural anesthesia: Highest risk—stop ≥72 hours pre, watch for hematoma (1:3,000-10,000 incidence).[3]
Postoperative Restart Timing
Restart 24-48 hours postop for low-risk procedures if hemostasis achieved; delay 48-72+ hours for high-risk. Monitor for thrombosis rebound.[4][5]
Sources
[1]: Xarelto Prescribing Information (FDA)
[2]: Andexxa Prescribing Information (FDA)
[3]: CHEST Guideline on Perioperative Management of Antithrombotics (2012, updated)
[4]: ACC Expert Consensus on Perioperative Anticoagulant Management
[5]: ASH Guidelines on Bridging Anticoagulation
[6]: PubMed: PCC for Rivaroxaban Reversal
[7]: Drugs.com: Xarelto Interactions